News | May 13, 2022
Increased prevalence of diabetes and product innovation to boost insulin pens market in India, says GlobalData
India has the second-largest number of adults with diabetes globally, after China
India has the second-largest number of adults with diabetes globally, after China
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors
Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
The start-up has announced the scheme to mark World Diabetes Day
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
Subscribe To Our Newsletter & Stay Updated
